Skip to main content
Accueil
  • fr
  • en

Main navigation

  • Company
    • Company profile
    • Management
      • Leadership Team
      • Supervisory Board
      • Strategic Advisory Board
    • Our history
  • Science
    • Scientific approach
    • Antibody formats
    • ANKET®: Our NK cell engager Platform
    • Publications
  • Products
    • Pipeline overview
    • Clinical trials
    • ------------------
    • IPH6501
    • IPH6101
    • IPH6401
    • IPH62
    • IPH4502
    • Lacutamab
    • Monalizumab
    • IPH5201
    • IPH5301
  • Partnering
  • Investors
    • Overview
    • News
    • Events
    • Stock Info
      • Share Information
      • Stock Quote & Chart
      • Analyst Coverage
    • Financial and Regulatory Information
      • Financial Reports
      • SEC Filings
      • Articles of Association
      • Number of Shares and Voting Rights
      • Share Repurchase Liquidity Agreement
      • Prospectus Related to Public Offering
      • Appraiser Reports
      • Regulated Agreements
    • General Shareholders Meeting
    • Governance
      • Corporate Governance
      • Management Team
    • Resources
      • Investor Email Alerts
  • Media
    • Media hub
    • All press releases
    • Media center
  • Careers
Menu

Supervisory Board

  1. Home
  2. Company
  3. Management
  4. Supervisory Board

Irina STAATZ-GRANZER, Chairwoman of the Supervisory Board

Founder and CEO of Staatz Business Development & Strategy

Pascale BOISSEL, Vice Chairperson of the Supervisory Board

Financial consultant and board member in the biotech and healthcare sector

Jean-Yves BLAY

General Director of the Centre Léon Bérard, Lyon

Sally Bennett

Co-Head Private & Syndicate Investments, HealthCor

Gilles BRISSON

Former Chairman of the Supervisory Board at Aventis Pharma SA.

Véronique CHABERNAUD

Founder and CEO of the company «Créer la Vitalité»

Bpifrance Participations represented by Olivier MARTINEZ

Senior Investment Director, Bpifrance

Related links

Leadership Team

Strategic Advisory Board

Footer

  • Contact
  • Location
  • Legal Info
  • Terms of use
  • Privacy Notice
  • Cookies notice
  • General Conditions of Purchase

Follow us

   

Stay in touch

 Subscribe to our newsletter

 Contact us
 

Location

117, Avenue de Luminy - BP 30191
13 009 Marseille FRANCE

 +33 (0)4 30 30 30 30

 Innate Pharma, Inc.
2273 Research Boulevard, Suite 350
Rockville, MD 20850, USA

Innate Pharma
  • Company
    • Company profile
    • Management
      • Leadership Team
      • Supervisory Board
      • Strategic Advisory Board
    • Our history
  • Science
    • Scientific approach
    • Antibody formats
    • ANKET®: Our NK cell engager Platform
    • Publications
  • Products
    • Pipeline overview
    • Clinical trials
    • ------------------
    • IPH6501
    • IPH6101
    • IPH6401
    • IPH62
    • IPH4502
    • Lacutamab
    • Monalizumab
    • IPH5201
    • IPH5301
  • Partnering
  • Investors
    • Overview
    • News
    • Events
    • Stock Info
      • Share Information
      • Stock Quote & Chart
      • Analyst Coverage
    • Financial and Regulatory Information
      • Financial Reports
      • SEC Filings
      • Articles of Association
      • Number of Shares and Voting Rights
      • Share Repurchase Liquidity Agreement
      • Prospectus Related to Public Offering
      • Appraiser Reports
      • Regulated Agreements
    • General Shareholders Meeting
    • Governance
      • Corporate Governance
      • Management Team
    • Resources
      • Investor Email Alerts
  • Media
    • Media hub
    • All press releases
    • Media center
  • Careers